The Cancer Genome Atlas (TCGA) database was used to explore the correlation between TREM2 expression and clinical outcome in patients with CRC using a threshold of 50% quantile as the cut-off for dividing patients into high- and low-expression groups. The gene discussed is TREM2; the disease is colorectal carcinoma.